Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

山東威高集團醫用高分子製品股份有限公司

Shandong Weigao Group Medical Polymer Company Limited*

(A joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code : 1066) PROPOSED AMENDMENT TO ARTICLES OF ASSOCIATION

The board of directors of Shandong Weigao Group Medical Polymer Company Limited (the "Company") would like to propose the amendment to Article 14 ("Proposed Amendment") of the Articles of Association of the Company. Details of the Proposed Amendment is as follows:-

Original Article 14

"Scope of operations: production and sale of medical polymer materials and products, plastic products (exclusive of agricultural film), sanitary raw and auxiliary materials, extracorporeal circulation and blood processing equipment, syringe and puncture devices, equipment and devices in the operation room, first-aid room and treatment room, clinical examination and analysis instruments, electronic devices, physiotherapy and rehabilitation equipment, medical cryotherapy, low temperature and refrigeration equipment and devices; production and sale of large-volume injection (including blood preservative solution), import and export of goods, import and export of technologies (excluding the distribution business of imported goods); medical supplies, pharmaceuticals, food, agricultural products, cosmetics, health products, such as irradiation sterilization, disinfection and treatment; irradiation technology consulting services. (Business projects that are subject to approval in accordance with law may only carried out after the approval of the relevant
departments, validity is subject to the permit granted.) ."

1

Be amended to:

"Scope of operations: production and sale of medical polymer materials and products, plastic products (exclusive of agricultural film), sanitary raw and auxiliary materials, extracorporeal circulation and blood processing equipment, syringe and puncture devices, equipment and devices in the operation room, first-aid room and treatment room, clinical examination and analysis instruments, electronic devices, physiotherapy and rehabilitation equipment, medical cryotherapy, low temperature and refrigeration equipment and devices; production and sale of large-volume injection (including blood preservative solution), production and sale of mould, import and export of goods, import and export of technologies (excluding the distribution business of imported goods); medical supplies, pharmaceuticals, food, agricultural products, cosmetics, health products, such as irradiation sterilization, disinfection and treatment; irradiation technology consulting services. (Business projects that are subject to approval in accordance with law may only carried out after the approval of the relevant departments, validity is subject to the permit granted.) ."
The proposed amendment to the Articles of Association is subject to approval of the shareholders by way of special resolution at the coming extraordinary general meeting (the "EGM") to be held on 19 October 2015 and the approval of and registration or filing with the relevant PRC government authorities.
A circular containing further information in respect of the proposed amendment to the Articles of Association and a notice of EGM will be despatched to the shareholders of the Company in due course.
The Proposed Amendment has been prepared in both Chinese and English. In the event of any discrepancy between the two versions, the Chinese version shall prevail.
By Order of the Board

Shandong Weigao Group Medical Polymer Company Limited Chen Xue Li

Chairman
20 August 2015
Weihai, Shandong, the PRC

2

As at the date of this announcement, the Board comprises:

Mr. Zhang Hua Wei (Executive Director)
Mr. Wang Yi (Executive Director)
Mr. Gong Jian Bo (Executive Director)
Mr. Xia Lie Bo (Executive Director)
Mr. Chen Xue Li (Non-executive Director)
Mrs. Zhou Shu Hua (Non-executive Director)
Mr. Lo Wai Hung(Independent non-executive Director)
Mr. Li Jia Miao (Independent non-executive Director)
Mrs. Fu Ming Zhong (Independent non-executive Director)
Mrs. Wang Jin Xia (Independent non-executive Director)

* For identification purpose only

3

distributed by